/Investor DB

Johnson & Johnson Innovation – JJDC — 2017 Investments

2 investments dated 2017 · listed companies and verified rows first · show all

Baebiesbaebies.comin𝕏Series B · Feb 2017 · $5M

Baebies develops multifunctional syndromic diagnostic testing using proprietary digital microfluidics, integrating molecular, immunoassay, chemistry, and coagulation testing into a single compact platform (FINDER) that runs on small-volume samples.

BiotechDeep TechDigital HealthHealthtechMedical DevicesResearch Triangle Park, US

Vamsee Pamula(Executive Officer, Director)in

BoardDennis Sacha(Director)William A. Hawkins(Director)

Co-investorsCharlotte Angel FundDuke Capital PartnersIAG Capital PartnersRex Health VenturesSolas BioVenturesVentureSouth+1 more

Hyalex Orthopaedicshyalex.comin𝕏Series A · May 2017 · $16M

HYALEX Orthopaedics develops a synthetic cartilage platform for joint repair in orthopaedic surgery.

HealthtechMedical DevicesLexington, US

Carl Vause(Chief Executive Officer and President)inMira Sahney(Executive Officer, Director)inDavid Myung(Director)

BoardMichael Hawkins(Director)Wende Hutton(Director)inWilliam Harrington(Director)in

Co-investorsCanaan PartnersOUP (Osage University Partners)Treo Ventures, Llc

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.